TY - JOUR
T1 - Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome
AU - Brito-Zerón, Pilar
AU - Acar-Denizli, Nihan
AU - Ng, Wan Fai
AU - Horváth, Ildiko Fanny
AU - Rasmussen, Astrid
AU - Seror, Raphaele
AU - Li, Xiaomei
AU - Baldini, Chiara
AU - Gottenberg, Jacques Eric
AU - Danda, Debashish
AU - Quartuccio, Luca
AU - Priori, Roberta
AU - Hernandez-Molina, Gabriela
AU - Armagan, Berkan
AU - Kruize, Aike A.
AU - Kwok, Seung Ki
AU - Kvarnstrom, Marika
AU - Praprotnik, Sonja
AU - Sene, Damien
AU - Gerli, Roberto
AU - Solans, Roser
AU - Rischmueller, Maureen
AU - Mandl, Thomas
AU - Suzuki, Yasunori
AU - Isenberg, David
AU - Valim, Valeria
AU - Wiland, Piotr
AU - Nordmark, Gunnel
AU - Fraile, Guadalupe
AU - Bootsma, Hendrika
AU - Nakamura, Hideki
AU - Giacomelli, Roberto
AU - Devauchelle-Pensec, Valerie
AU - Hofauer, Benedikt
AU - Bombardieri, Michele
AU - Trevisani, Virginia Fernandes Moça
AU - Hammenfors, Daniel
AU - Pasoto, Sandra G.
AU - Retamozo, Soledad
AU - Gheita, Tamer A.
AU - Atzeni, Fabiola
AU - Morel, Jacques
AU - Vollenweider, Cristina
AU - Zeher, Margit
AU - Sivils, Kathy
AU - Xu, Bei
AU - Bombardieri, Stefano
AU - Sandhya, Pulukool
AU - De Vita, Salvatore
AU - Minniti, Antonina
AU - Sánchez-Guerrero, Jorge
AU - Kilic, Levent
AU - Van Der Heijden, Eefje
AU - Park, Sung Hwan
AU - Wahren-Herlenius, Marie
AU - Mariette, Xavier
AU - Ramos-Casals, Manuel
N1 - Publisher Copyright:
© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: [email protected].
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Objective: To characterize the systemic phenotype of primary Sjögren's syndrome at diagnosis by analysing the EULAR-SS disease activity index (ESSDAI) scores. Methods: The Sjögren Big Data Consortium is an international, multicentre registry based on worldwide data-sharing cooperative merging of pre-existing databases from leading centres in clinical research in Sjögren's syndrome from the five continents. Results: The cohort included 10 007 patients (9352 female, mean 53 years) with recorded ESSDAI scores available. At diagnosis, the mean total ESSDAI score was 6.1; 81.8% of patients had systemic activity (ESSDAI score ≥1). Males had a higher mean ESSDAI (8.1 vs 6.0, P < 0.001) compared with females, as did patients diagnosed at <35 years (6.7 vs 5.6 in patients diagnosed at >65 years, P < 0.001). The highest global ESSDAI score was reported in Black/African Americans, followed by White, Asian and Hispanic patients (6.7, 6.5, 5.4 and 4.8, respectively; P < 0.001). The frequency of involvement of each systemic organ also differed between ethnic groups, with Black/African American patients showing the highest frequencies in the lymphadenopathy, articular, peripheral nervous system, CNS and biological domains, White patients in the glandular, cutaneous and muscular domains, Asian patients in the pulmonary, renal and haematological domains and Hispanic patients in the constitutional domain. Systemic activity measured by the ESSDAI, clinical ESSDAI (clinESSDAI) and disease activity states was higher in patients from southern countries (P < 0.001). Conclusion: The systemic phenotype of primary Sjögren's syndrome is strongly influenced by personal determinants such as age, gender, ethnicity and place of residence, which are key geoepidemiological players in driving the expression of systemic disease at diagnosis.
AB - Objective: To characterize the systemic phenotype of primary Sjögren's syndrome at diagnosis by analysing the EULAR-SS disease activity index (ESSDAI) scores. Methods: The Sjögren Big Data Consortium is an international, multicentre registry based on worldwide data-sharing cooperative merging of pre-existing databases from leading centres in clinical research in Sjögren's syndrome from the five continents. Results: The cohort included 10 007 patients (9352 female, mean 53 years) with recorded ESSDAI scores available. At diagnosis, the mean total ESSDAI score was 6.1; 81.8% of patients had systemic activity (ESSDAI score ≥1). Males had a higher mean ESSDAI (8.1 vs 6.0, P < 0.001) compared with females, as did patients diagnosed at <35 years (6.7 vs 5.6 in patients diagnosed at >65 years, P < 0.001). The highest global ESSDAI score was reported in Black/African Americans, followed by White, Asian and Hispanic patients (6.7, 6.5, 5.4 and 4.8, respectively; P < 0.001). The frequency of involvement of each systemic organ also differed between ethnic groups, with Black/African American patients showing the highest frequencies in the lymphadenopathy, articular, peripheral nervous system, CNS and biological domains, White patients in the glandular, cutaneous and muscular domains, Asian patients in the pulmonary, renal and haematological domains and Hispanic patients in the constitutional domain. Systemic activity measured by the ESSDAI, clinical ESSDAI (clinESSDAI) and disease activity states was higher in patients from southern countries (P < 0.001). Conclusion: The systemic phenotype of primary Sjögren's syndrome is strongly influenced by personal determinants such as age, gender, ethnicity and place of residence, which are key geoepidemiological players in driving the expression of systemic disease at diagnosis.
KW - ethnicity
KW - gender
KW - geoepidemiology
KW - phenotype
KW - primary Sjögren's syndrome
UR - http://www.scopus.com/inward/record.url?scp=85078897832&partnerID=8YFLogxK
U2 - 10.1093/rheumatology/kez578
DO - 10.1093/rheumatology/kez578
M3 - Article
C2 - 31873754
AN - SCOPUS:85078897832
SN - 1462-0324
VL - 59
SP - 2350
EP - 2359
JO - Rheumatology
JF - Rheumatology
IS - 9
ER -